Form 4: Corvus Pharmaceuticals CEO Richard Miller Reports Gift of Shares

Richard A. Miller, CEO of Corvus Pharmaceuticals, reported a gift of 302,016 common stock shares and maintains beneficial ownership of 577,634 shares directly and 1,188,103 shares indirectly through a trust.

Summary

• On May 10, 2024, Richard A. Miller, the President and CEO of Corvus Pharmaceuticals, reported a transaction involving the company's common stock.
• Miller gifted 302,016 shares of common stock.
• Following the transaction, Miller directly owns 577,634 shares.
• Miller also indirectly owns 1,188,103 shares through the Miller-Horning Family Trust.
• Dr. Miller shares voting, investment, and dispositive power over the shares held by the Miller-Horning Trust.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing a gift of shares. It doesn't inherently convey positive or negative sentiment about the company's performance or future prospects.

Industry Context

This is a standard SEC Form 4 filing, which is required when a company insider, such as a CEO or director, makes a transaction in the company's stock. It provides transparency to the market regarding insider activity.

Stakeholder Impact

• The transaction may have a minor impact on shareholders by slightly reducing the CEO's direct holdings, but the indirect holdings remain substantial.

Key Dates